209 related articles for article (PubMed ID: 16298376)
21. GC-MS analysis of the lipophilic principles of Echinacea purpurea and evaluation of cucumber mosaic cucumovirus infection.
Hudaib M; Fiori J; Bellardi MG; Rubies-Autonell C; Cavrini V
J Pharm Biomed Anal; 2002 Aug; 29(6):1053-60. PubMed ID: 12110390
[TBL] [Abstract][Full Text] [Related]
22. Effect of temperature on stability of marker constituents in Echinacea purpurea root formulations.
Livesey J; Awang DV; Arnason JT; Letchamo W; Barrett M; Pennyroyal G
Phytomedicine; 1999 Nov; 6(5):347-9. PubMed ID: 11962542
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous determination and pharmacokinetic study of four phenol compounds in rat plasma by ultra-high performance liquid chromatography with tandem mass spectrometry after oral administration of Echinacea purpurea extract.
Gan C; Liu L; Du Y; Wang L; Gao M; Wu L; Yang C
J Sep Sci; 2016 May; 39(9):1628-37. PubMed ID: 26924074
[TBL] [Abstract][Full Text] [Related]
24. Caffeic acid derivatives production by hairy root cultures of Echinacea purpurea.
Liu CZ; Abbasi BH; Gao M; Murch SJ; Saxena PK
J Agric Food Chem; 2006 Nov; 54(22):8456-60. PubMed ID: 17061821
[TBL] [Abstract][Full Text] [Related]
25. Establishment of adventitious root cultures of Echinacea purpurea for the production of caffeic acid derivatives.
Paek KY; Murthy HN; Hahn EJ
Methods Mol Biol; 2009; 547():3-16. PubMed ID: 19521831
[TBL] [Abstract][Full Text] [Related]
26. Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestion.
Matthias A; Addison RS; Penman KG; Dickinson RG; Bone KM; Lehmann RP
Life Sci; 2005 Sep; 77(16):2018-29. PubMed ID: 15919096
[TBL] [Abstract][Full Text] [Related]
27. Stabilization of caffeic acid derivatives in Echinacea purpurea L. glycerin extract.
Bergeron C; Gafner S; Batcha LL; Angerhofer CK
J Agric Food Chem; 2002 Jul; 50(14):3967-70. PubMed ID: 12083867
[TBL] [Abstract][Full Text] [Related]
28. Phytochemical variation in echinacea from roots and flowerheads of wild and cultivated populations.
Binns SE; Livesey JF; Arnason JT; Baum BR
J Agric Food Chem; 2002 Jun; 50(13):3673-87. PubMed ID: 12059142
[TBL] [Abstract][Full Text] [Related]
29. Comparison of chemical components and antioxidants capacity of different Echinacea species.
Sloley BD; Urichuk LJ; Tywin C; Coutts RT; Pang PK; Shan JJ
J Pharm Pharmacol; 2001 Jun; 53(6):849-57. PubMed ID: 11428661
[TBL] [Abstract][Full Text] [Related]
30. Efficient counter-current chromatographic isolation and structural identification of two new cinnamic acids from Echinacea purpurea.
Lu Y; Li J; Li M; Hu X; Tan J; Liu ZH
Nat Prod Commun; 2012 Oct; 7(10):1353-6. PubMed ID: 23157008
[TBL] [Abstract][Full Text] [Related]
31. A sensitive LC-MS/MS method for the quantitative analysis of the Echinacea purpurea constituent undeca-2-ene-8,10-diynoic acid isobutylamide in human plasma.
Goey AK; Sparidans RW; Meijerman I; Rosing H; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jan; 879(1):41-8. PubMed ID: 21123121
[TBL] [Abstract][Full Text] [Related]
32. Optimization and single-laboratory validation study of a high-performance liquid chromatography (HPLC) method for the determination of phenolic Echinacea constituents.
Brown PN; Chan M; Betz JM
Anal Bioanal Chem; 2010 Jul; 397(5):1883-92. PubMed ID: 20467727
[TBL] [Abstract][Full Text] [Related]
33. Echinacea alkylamides inhibit interleukin-2 production by Jurkat T cells.
Sasagawa M; Cech NB; Gray DE; Elmer GW; Wenner CA
Int Immunopharmacol; 2006 Jul; 6(7):1214-21. PubMed ID: 16714226
[TBL] [Abstract][Full Text] [Related]
34. Effects of chemically characterized fractions from aerial parts of Echinacea purpurea and E. angustifolia on myelopoiesis in rats.
Ramasahayam S; Baraka HN; Abdel Bar FM; Abuasal BS; Widrlechner MP; Sayed KA; Meyer SA
Planta Med; 2011 Nov; 77(17):1883-9. PubMed ID: 21870322
[TBL] [Abstract][Full Text] [Related]
35. Application of HPLC Fingerprint Combined with Chemical Pattern Recognition and Multi-Component Determination in Quality Evaluation of
Lv X; Feng S; Zhang J; Sun S; Geng Y; Yang M; Liu Y; Qin L; Zhao T; Wang C; Liu G; Li F
Molecules; 2022 Sep; 27(19):. PubMed ID: 36235000
[No Abstract] [Full Text] [Related]
36. Preparative separation of cichoric acid from Echinacea purpurea by pH-zone-refining counter-current chromatography.
Wang X; Geng Y; Li F; Gao Q; Shi X
J Chromatogr A; 2006 Jan; 1103(1):166-9. PubMed ID: 16364342
[TBL] [Abstract][Full Text] [Related]
37. Investigation of phenolic constituents in Echinacea purpurea grown in China.
Liu YC; Zeng JG; Chen B; Yao SZ
Planta Med; 2007 Dec; 73(15):1600-5. PubMed ID: 18058611
[TBL] [Abstract][Full Text] [Related]
38. Absolute/relative bioavailability and metabolism of dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides (tetraenes) after intravenous and oral single doses to rats.
Ardjomand-Woelkart K; Kollroser M; Magnes C; Sinner F; Frye RF; Derendorf H; Bauer R; Butterweck V
Planta Med; 2011 Nov; 77(16):1794-9. PubMed ID: 21604240
[TBL] [Abstract][Full Text] [Related]
39. Carbon nanotube reinforced hollow fiber solid/liquid phase microextraction: a novel extraction technique for the measurement of caffeic acid in Echinacea purpurea herbal extracts combined with high-performance liquid chromatography.
Es'haghi Z; Golsefidi MA; Saify A; Tanha AA; Rezaeifar Z; Alian-Nezhadi Z
J Chromatogr A; 2010 Apr; 1217(17):2768-75. PubMed ID: 20227700
[TBL] [Abstract][Full Text] [Related]
40. Metabolomic profiling of liquid Echinacea medicinal products with in vitro inhibitory effects on cytochrome P450 3A4 (CYP3A4).
Modarai M; Yang M; Suter A; Kortenkamp A; Heinrich M
Planta Med; 2010 Mar; 76(4):378-85. PubMed ID: 19790031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
